Effectiveness of Foot Bathing, Massage, and Range of Motion Exercise on patients with Diabetic Peripheral Neuropathy: A Clinical Trial
- Conditions
- Diabetes Mellitus.Idiopathic peripheral autonomic neuropathyG90.0
- Registration Number
- IRCT20221220056877N1
- Lead Sponsor
- niversity of Baghdad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Patients who are more than or equal to 18 years old
Patients who have been diagnosed with diabetes for 10 years and more
Patients who have Diabetic Peripheral Neuropathy (DPN) of more than 5 on Toronto Clinical neuropathy score (TCNS)
Patients with Type-1 and Type-2 Diabetes Mellitus
Patients with score of 5 and less than in TCNS scale
Patients who have Chemotherapy-Induced Peripheral Neuropathy
Patients with foot gangrene
Patients with amputated right or left foot
Patients who refused to participate in the study
Patients with paralysis, partly or entirely unable to move the affected parts of the body
patients with osteoarthritis and osteomyelitis, rheumatoid arthritis
Patient with certain viral or bacterial infections, including Lyme disease, shingles, Epstein-Barr virus, hepatitis B and C, leprosy, Diphtheria, and HIV)
Patients who are receiving any physiotherapy intervention
Patients with inherited disorders, such as Charcot-Marie-Tooth disease are hereditary types of neuropathy;
Patients with autoimmune diseases, include lupus, Guillain-Barre syndrome, demyelinating polyneuropathy and vasculitis
Patients with bone marrow disorders, These include Multiple myeloma, lymphoma and amyloidosis
Patients with other diseases, include kidney and liver disease, connective tissue disorders and hypothyroidism)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome variable is the level of Diabetic Peripheral Neuropathy that can be changed based on foot bathing, foot massage, and ROM exercises. Timepoint: Before intervention and two weeks after intervention. Method of measurement: The Toronto Clinical Neuropathy Score will be used to assess the level of DPN.
- Secondary Outcome Measures
Name Time Method